NCT07901452Completed
Effects of an APP Based Rehabilitation Intervention on Activities of Daily Living and Physical Performance in Patients With Post-Stroke Hemiplegia
Source: ClinicalTrials.gov · Last updated 28 Oct 2026
Brief summary (registry, in English)
This study aims to evaluate the effects of an AI-enabled mobile rehabilitation application combined with conventional rehabilitation on activities of daily living and physical performance among patients with post-stroke hemiplegia over a 3 month period.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 46 (actual)
- First submitted
- 17 Oct 2026
- Start date
- 13 Sept 2023
- Primary completion date
- 20 Jun 2025
- Lead sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Diseases
- Stroke
- NCT number
- NCT07901452
What you commit to
- Study type: Interventional
- Participants enrolled: 46
- From 13 Sept 2023 to the primary completion date, 20 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Clinically unstable condition preventing participation.
- Diagnosed with dementia.
Other
- Concurrently enrolled in other interventional studies.
- Unable to operate a smartphone.
Who the study is looking for
- Diagnosed with stroke and unilateral hemiplegia.
- Aged between 20 and 85 years.
- Possesses a smartphone or tablet.
Age in the registry: 20 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kaohsiung Medical University Chung-Ho Memorial Hospital Coordinator of this site? Confirm its status | Kaohsiung City | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.